Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice

Particle and Fibre Toxicology

Volumn 8, Issue , 2011, Pages

  Wang, Xiaojia ^a   Katwa, Pranita ^a   Podila, Ramakrishna ^b   Chen, Pengyu ^b   Ke, Pu Chun ^b   Rao, Apparao M ^b   Walters, Dianne M ^a   Wingard, Christopher J ^a   Brown, Jared M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

Ccl11Mmp13; Ccl3; Flexivent; IL 33; MWCNT; Pulmonary fibrosis; Pulmonary function; Raman spectroscopy

Indexed keywords

COLLAGEN; COLLAGENASE 3; EOTAXIN; INTERLEUKIN 33; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MULTI WALLED NANOTUBE; CARBON NANOTUBE; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG COMPLIANCE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG GRANULOMA; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PULMONARY ASPIRATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG INSTILLATION; EXPOSURE; IMMUNOLOGY; LUNG; LUNG LAVAGE; METABOLISM; PARTICLE SIZE; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

MUS;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGEN; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; INHALATION EXPOSURE; INSTILLATION, DRUG; LUNG; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOTUBES, CARBON; PARTICLE SIZE; PNEUMONIA; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; SURFACE PROPERTIES;

EID: 80051788917     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-8-24     Document Type: Article

References (43)

1. Martin CR, Kohli P. The emerging field of nanotube biotechnology. Nat Rev Drug Discov 2003, 2:29-37. 10.1038/nrd988, 12509757.
2. Inoue K, Koike E, Yanagisawa R, Hirano S, Nishikawa M, Takano H. Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol Appl Pharmacol 2009, 237:306-316. 10.1016/j.taap.2009.04.003, 19371758.
3. Inoue K, Takano H, Koike E, Yanagisawa R, Sakurai M, Tasaka S, Ishizaka A, Shimada A. Effects of pulmonary exposure to carbon nanotubes on lung and systemic inflammation with coagulatory disturbance induced by lipopolysaccharide in mice. Exp Biol Med (Maywood) 2008, 233:1583-1590.
4. Porter DW, Hubbs AF, Mercer RR, Wu N, Wolfarth MG, Sriram K, Leonard S, Battelli L, Schwegler-Berry D, Friend S, et al. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010, 269:136-147. 10.1016/j.tox.2009.10.017, 19857541.
5. Ma-Hock L, Treumann S, Strauss V, Brill S, Luizi F, Mertler M, Wiench K, Gamer AO, Van RB, Landsiedel R. Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol Sci 2009, 112:468-481. 10.1093/toxsci/kfp146, 19584127.
6. Cesta MF, Ryman-Rasmussen JP, Wallace DG, Masinde T, Hurlburt G, Taylor AJ, Bonner JC. Bacterial lipopolysaccharide enhances PDGF signaling and pulmonary fibrosis in rats exposed to carbon nanotubes. Am J Respir Cell Mol Biol 2010, 43:142-151. 10.1165/rcmb.2009-0113OC, 2937228, 19738159.
7. Ryman-Rasmussen JP, Tewksbury EW, Moss OR, Cesta MF, Wong BA, Bonner JC. Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. Am J Respir Cell Mol Biol 2009, 40:349-358. 2645533, 18787175.
8. North ML, Amatullah H, Khanna N, Urch B, Grasemann H, Silverman F, Scott JA. Augmentation of arginase 1 expression by exposure to air pollution exacerbates the airways hyperresponsiveness in murine models of asthma. Respir Res 2011, 12:19. 10.1186/1465-9921-12-19, 3037317, 21291525.
9. Hamilton RF, Buford MC, Wood MB, Arnone B, Morandi M, Holian A. Engineered carbon nanoparticles alter macrophage immune function and initiate airway hyper-responsiveness in the BALB/c mouse model. Nanotoxicology 2007, 1:104-117.
10. Vanoirbeek JA, Rinaldi M, De V, Haenen S, Bobic S, Gayan-Ramirez G, Hoet PH, Verbeken E, Decramer M, Nemery B, et al. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol 2010, 42:96-104. 10.1165/rcmb.2008-0487OC, 19346316.
11. Glaab T, Taube C, Braun A, Mitzner W. Invasive and noninvasive methods for studying pulmonary function in mice. Respir Res 2007, 8:63. 10.1186/1465-9921-8-63, 2039738, 17868442.
12. Shalaby KH, Gold LG, Schuessler TF, Martin JG, Robichaud A. Combined forced oscillation and forced expiration measurements in mice for the assessment of airway hyperresponsiveness. Respir Res 2010, 11:82. 10.1186/1465-9921-11-82, 2904286, 20565957.
13. Navajas D, Farre R. Forced oscillation assessment of respiratory mechanics in ventilated patients. Crit Care 2001, 5:3-9. 137264, 11178220.
14. Sellares J, Acerbi I, Loureiro H, Dellaca RL, Ferrer M, Torres A, Navajas D, Farre R. Respiratory impedance during weaning from mechanical ventilation in a mixed population of critically ill patients. Br J Anaesth 2009, 103:828-832. 10.1093/bja/aep301, 19887532.
15. Han SG, Andrews R, Gairola CG. Acute pulmonary response of mice to multi-wall carbon nanotubes. Inhal Toxicol 2010, 22:340-347. 10.3109/08958370903359984, 20064106.
16. Reddy ARN, Reddy YN, Krishna DR, Himabindu V. Pulmonary toxicity assessment of multiwalled carbon nanotubes in rats following intratracheal instillation. Environ Toxicol 2010, n/a.
17. Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, Arras M, Fonseca A, Nagy JB, Lison D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 2005, 207:221-231. 10.1016/j.taap.2005.01.008, 16129115.
18. Mitchell LA, Gao J, Wal RV, Gigliotti A, Burchiel SW, McDonald JD. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci 2007, 100:203-214. 10.1093/toxsci/kfm196, 17660506.
19. Demou E, Peter P, Hellweg S. Exposure to manufactured nanostructured particles in an industrial pilot plant. Ann Occup Hyg 2008, 52:695-706. 10.1093/annhyg/men058, 18931382.
20. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A 2004, 67:87-107. 10.1080/15287390490253688, 14668113.
21. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005, 289:L698-L708. 10.1152/ajplung.00084.2005, 15951334.
22. NIOSH Current Intelligence Bulletin: Occupation Exposure to Carbon Nanotubes and Nanofibers 2010, NIOSH.
23. Wang L, Castranova V, Mishra A, Chen B, Mercer RR, Schwegler-Berry D, Rojanasakul Y. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol 2010, 7:31. 10.1186/1743-8977-7-31, 2970581, 20958985.
24. Huizar I, Malur A, Midgette YA, Kukoly C, Chen P, Ke PC, Podila R, Rao AM, Wingard CJ, Dobbs L, et al. Novel Murine Model of Chronic Granulomatous Lung Inflammation Elicited by Carbon Nanotubes. Am J Respir Cell Mol Biol 2011,
25. Kamata H, Tasaka S, Inoue K, Miyamoto K, Nakano Y, Shinoda H, Kimizuka Y, Fujiwara H, Ishii M, Hasegawa N, et al. Carbon black nanoparticles enhance bleomycin-induced lung inflammatory and fibrotic changes in mice. Exp Biol Med (Maywood) 2011, 236:315-324.
26. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Schwegler-Berry D, Castranova V, Porter DW. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol 2010, 7:28. 10.1186/1743-8977-7-28, 2958975, 20920331.
27. Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, Pardo A. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?. Am J Physiol Lung Cell Mol Physiol 2000, 279:L562-L574.
28. Kim EJ, Cho HJ, Park D, Kim JY, Kim YB, Park TG, Shim CK, Oh YK. Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acid. Mol Ther 2011, 19:355-361. 10.1038/mt.2010.262, 21139571.
29. Flechsig P, Hartenstein B, Teurich S, Dadrich M, Hauser K, Abdollahi A, Grone HJ, Angel P, Huber PE. Loss of matrix metalloproteinase-13 attenuates murine radiation-induced pulmonary fibrosis. Int J Radiat Oncol Biol Phys 2010, 77:582-590. 10.1016/j.ijrobp.2009.12.043, 20457355.
30. Dipietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 1998, 101:1693-1698. 10.1172/JCI1020, 508751, 9541500.
31. Emad A, Emad Y. Relationship Between Eosinophilia and Levels of Chemokines (CCL5 and CCL11) and IL-5 in Bronchoalveolar Lavage Fluid of Patients With Mustard Gas-Induced Pulmonary Fibrosis. Journal of Clinical Immunology 2007, 27:605-612. 10.1007/s10875-007-9114-y, 17620002.
32. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, et al. IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines. Immunity 2005, 23:479-490. 10.1016/j.immuni.2005.09.015, 16286016.
33. Lloyd CM. IL-33 family members and asthma - bridging innate and adaptive immune responses. Current Opinion in Immunology 2010, 22:800-806. 10.1016/j.coi.2010.10.006, 21071194.
34. Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Knchler AM. Interleukin-33 - cytokine of dual function or novel alarmin?. Trends in Immunology 2009, 30:227-233. 10.1016/j.it.2009.03.003, 19359217.
35. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Current Opinion in Immunology 2005, 17:359-365. 10.1016/j.coi.2005.06.002, 15955682.
36. Komai-Koma M, Xu D, Li Y, McKenzie A, McInnes I, Liew F. IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 2007, 37:2779-2786. 10.1002/eji.200737547, 17853410.
37. Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan CJ, Ying S, Pitman N, Mirchandani A, Rana B, van Rooijen N, et al. IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation. The Journal of Immunology 2009, 183:6469-6477. 10.4049/jimmunol.0901575, 19841166.
38. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010, 10:103-110. 10.1038/nri2692, 20081870.
39. Mangan N, Dasvarma A, McKenzie A, Fallon P. T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation. Eur J Immunol 2007, 37:1302-1312. 10.1002/eji.200636520, 17407196.
40. Kearley J, Buckland KF, Mathie SA, Lloyd CM. Resolution of Allergic Inflammation and Airway Hyperreactivity Is Dependent upon Disruption of the T1/ST2-IL-33 Pathway. Am J Respir Crit Care Med 2009, 179:772-781. 10.1164/rccm.200805-666OC, 2675564, 19179489.
41. Wingard CJ, Walters DM, Cathey BL, Hilderbrand SC, Katwa P, Lin S, Ke PC, Podila R, Rao A, Lust RM, et al. Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. Nanotoxicology 2010,
42. Brunauer S, Emmett PH, Teller E. Adsorption of Gases in Multimolecular Layers. J Am Chem Soc 1938, 60:309-319.
43. Barrett EP, Joyner LG, Halenda PP. The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. J Am Chem Soc 1951, 73:373-380.